[시장보고서]재조합 단백질 제조 서비스 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 서비스 유형별, 숙주 세포별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

재조합 단백질 제조 서비스 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 서비스 유형별, 숙주 세포별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Recombinant Proteins Manufacturing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service Type, By Host Cell, By End-user, By Region and Competition, 2020-2030F

상품코드 : 1881510

리서치사 : TechSci Research

발행일 : 2025년 11월

페이지 정보 : 영문 185 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,699,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 8,188,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,910,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 재조합 단백질 제조 서비스 시장은 2024년에 37억 6,000만 달러로 평가되었으며, 2030년까지 CAGR 7.41%로 성장하여 57억 7,000만 달러에 달할 것으로 예측됩니다.

재조합 단백질은 특정 유전물질을 숙주 세포에 도입하여 인위적으로 생성된 단백질로, 치료, 진단, 연구 등 다양한 용도를 위한 대규모 생산이 가능합니다. 이 분야의 제조 서비스 시장은 기본적으로 바이오의약품 연구개발에 대한 세계 투자 증가, 생물학적 제제 및 바이오시밀러에 대한 수요 증가, 고도의 단백질 기반 요법을 필요로 하는 만성질환의 증가 등의 요인에 의해 주도되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	37억 6,000만 달러
시장 규모 : 2030년	57억 7,000만 달러
CAGR : 2025-2030년	7.41%
가장 빠르게 성장하는 부문	전임상·임상 서비스
최대 시장	북미

주요 시장 촉진요인

바이오로직스 및 바이오시밀러에 대한 수요 증가는 세계 재조합 단백질 제조 서비스 시장의 주요 촉진요인입니다. 이러한 첨단 치료 제품들은 재조합 단백질 기술을 활용하여 다양한 질환에 대응하고 있으며, 그 채택 확대에 따라 전문적인 생산능력이 요구되고 있습니다.

주요 시장 과제

최적의 단백질 발현 달성, 정제 시 고순도 확보, 일관된 제품 품질 및 안정성 유지는 고유의 복잡성을 수반하며, 이는 세계 재조합 단백질 제조 서비스 시장의 성장에 큰 장벽으로 작용하고 있습니다. 단백질 응집 문제, 다양한 발현 시스템에서 엄격한 규제 준수 필요성 등 이러한 기술적 과제는 재조합 단백질 제품의 운영 비용 상승과 개발 기간의 장기화로 직결됩니다.

주요 시장 동향

바이오의약품 분야에서 전문 업체에 대한 아웃소싱 확대는 세계 재조합 단백질 제조 서비스 시장을 크게 형성하고 있습니다. 이러한 추세는 제약사 및 바이오기업들이 위탁개발생산기관(CDMO)이 제공하는 외부 전문 지식, 첨단 기술, 확장 가능한 생산능력을 활용하려는 전략적 전환을 반영하고 있습니다.

시장 규모 및 예측
- 금액별
시장 점유율과 예측
- 서비스 유형별(전임상·임상 서비스, 상업 생산 서비스)
- 호스트 세포별(포유류 세포, 세균 세포, 곤충 세포, 효모·진균, 기타)
- 최종사용자별(제약·바이오테크놀러지 기업, 학술·연구기관)
- 지역별
- 기업별(2024)
시장 맵

제6장 북미의 재조합 단백질 제조 서비스 시장 전망

시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코

제7장 유럽의 재조합 단백질 제조 서비스 시장 전망

시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인

제8장 아시아태평양의 재조합 단백질 제조 서비스 시장 전망

시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주

제9장 중동 및 아프리카의 재조합 단백질 제조 서비스 시장 전망

시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
- 사우디아라비아
- 아랍에미리트
- 남아프리카공화국

제10장 남미의 재조합 단백질 제조 서비스 시장 전망

시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
- 브라질
- 콜롬비아
- 아르헨티나

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

인수합병
제품 출시
최근 동향

제13장 세계의 재조합 단백질 제조 서비스 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협

제15장 경쟁 구도

Lonza Group Ltd.
Boehringer Ingelheim International GmbH
FUJIFILM Diosynth Biotechnologies USA, Inc.
Merck KGaA
Bruker Corporation
Sino Biological, Inc.
GenScript Biotech Corporation
Kaneka Corporation
Polyplus Transfection S.A.
Boster Biological Technology Co., Ltd.

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

영문 목차

영문목차

The Global Recombinant Proteins Manufacturing Services Market, valued at USD 3.76 Billion in 2024, is projected to experience a CAGR of 7.41% to reach USD 5.77 Billion by 2030. Recombinant proteins are artificially engineered proteins generated by introducing specific genetic material into host cells, enabling their large-scale production for diverse applications, including therapeutic, diagnostic, and research purposes. The market for manufacturing services in this sector is fundamentally driven by increasing global investments in biopharmaceutical research and development, the expanding demand for biologics and biosimilars, and the growing prevalence of chronic diseases requiring advanced protein-based therapies.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 3.76 Billion
Market Size 2030	USD 5.77 Billion
CAGR 2025-2030	7.41%
Fastest Growing Segment	Pre-clinical & Clinical Services
Largest Market	North America

Key Market Drivers

The rising demand for biologics and biosimilars is a primary driver for the global recombinant proteins manufacturing services market. These advanced therapeutic products, leveraging recombinant protein technology, address diverse diseases, and their growing adoption demands specialized production capabilities. Patent expirations for originator biologics have notably fueled the biosimilars sector, increasing product development. Recombinant protein service manufacturers are crucial in supporting this pipeline, providing expertise and infrastructure for complex biological production. This pursuit of more affordable treatments strengthens market demand; according to a study published by RAND Corporation in January 2022, biosimilar drugs are expected to generate savings estimated at USD 38.4 billion of projected total U. S. expenditure on biologics from 2021 to 2025. This economic benefit underscores the need for efficient and scalable manufacturing services.

Key Market Challenges

The inherent complexities in achieving optimal protein expression, ensuring high purity during purification, and maintaining consistent product quality and stability pose a significant impediment to the growth of the global recombinant proteins manufacturing services market. These technical hurdles, including issues such as protein aggregation and the necessity for stringent regulatory compliance across diverse expression systems, directly lead to elevated operational costs and extended development timelines for recombinant protein products. This significantly increases the financial burden on manufacturers and developers.

Key Market Trends

The expansion of biopharmaceutical outsourcing to specialized providers continues to significantly shape the Global Recombinant Proteins Manufacturing Services Market. This trend reflects a strategic shift by pharmaceutical and biotechnology companies to leverage external expertise, advanced technologies, and scalable capacity offered by contract development and manufacturing organizations. This allows companies to optimize resource allocation, reduce capital expenditure, and accelerate time to market for complex protein-based therapies. Lonza's CDMO business, for instance, reported robust performance in its first half of 2025, with sales delivering a 23.1% growth at constant exchange rates. This substantial growth underscores the sustained demand for specialized outsourcing services within the industry.

Key Market Players

Lonza Group Ltd.
Boehringer Ingelheim International GmbH
FUJIFILM Diosynth Biotechnologies USA, Inc.
Merck KGaA
Bruker Corporation
Sino Biological, Inc.
GenScript Biotech Corporation
Kaneka Corporation
Polyplus Transfection S.A.
Boster Biological Technology Co., Ltd.

Report Scope:

In this report, the Global Recombinant Proteins Manufacturing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Recombinant Proteins Manufacturing Services Market, By Service Type:

Pre-clinical & Clinical Services
Commercial Production Services

Recombinant Proteins Manufacturing Services Market, By Host Cell:

Mammalian Cells
Bacterial Cells
Insect Cells
Yeast & Fungi
Others

Recombinant Proteins Manufacturing Services Market, By End-user:

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes

Recombinant Proteins Manufacturing Services Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Recombinant Proteins Manufacturing Services Market.

Available Customizations:

Global Recombinant Proteins Manufacturing Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Recombinant Proteins Manufacturing Services Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Service Type (Pre-clinical & Clinical Services, Commercial Production Services)
- 5.2.2. By Host Cell (Mammalian Cells, Bacterial Cells, Insect Cells, Yeast & Fungi, Others)
- 5.2.3. By End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Recombinant Proteins Manufacturing Services Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Service Type
- 6.2.2. By Host Cell
- 6.2.3. By End-user
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Recombinant Proteins Manufacturing Services Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Service Type
    - 6.3.1.2.2. By Host Cell
    - 6.3.1.2.3. By End-user
- 6.3.2. Canada Recombinant Proteins Manufacturing Services Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Service Type
    - 6.3.2.2.2. By Host Cell
    - 6.3.2.2.3. By End-user
- 6.3.3. Mexico Recombinant Proteins Manufacturing Services Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Service Type
    - 6.3.3.2.2. By Host Cell
    - 6.3.3.2.3. By End-user

7. Europe Recombinant Proteins Manufacturing Services Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Service Type
- 7.2.2. By Host Cell
- 7.2.3. By End-user
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Recombinant Proteins Manufacturing Services Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Service Type
    - 7.3.1.2.2. By Host Cell
    - 7.3.1.2.3. By End-user
- 7.3.2. France Recombinant Proteins Manufacturing Services Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Service Type
    - 7.3.2.2.2. By Host Cell
    - 7.3.2.2.3. By End-user
- 7.3.3. United Kingdom Recombinant Proteins Manufacturing Services Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Service Type
    - 7.3.3.2.2. By Host Cell
    - 7.3.3.2.3. By End-user
- 7.3.4. Italy Recombinant Proteins Manufacturing Services Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Service Type
    - 7.3.4.2.2. By Host Cell
    - 7.3.4.2.3. By End-user
- 7.3.5. Spain Recombinant Proteins Manufacturing Services Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Service Type
    - 7.3.5.2.2. By Host Cell
    - 7.3.5.2.3. By End-user

8. Asia Pacific Recombinant Proteins Manufacturing Services Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Service Type
- 8.2.2. By Host Cell
- 8.2.3. By End-user
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Recombinant Proteins Manufacturing Services Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Service Type
    - 8.3.1.2.2. By Host Cell
    - 8.3.1.2.3. By End-user
- 8.3.2. India Recombinant Proteins Manufacturing Services Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Service Type
    - 8.3.2.2.2. By Host Cell
    - 8.3.2.2.3. By End-user
- 8.3.3. Japan Recombinant Proteins Manufacturing Services Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Service Type
    - 8.3.3.2.2. By Host Cell
    - 8.3.3.2.3. By End-user
- 8.3.4. South Korea Recombinant Proteins Manufacturing Services Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Service Type
    - 8.3.4.2.2. By Host Cell
    - 8.3.4.2.3. By End-user
- 8.3.5. Australia Recombinant Proteins Manufacturing Services Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Service Type
    - 8.3.5.2.2. By Host Cell
    - 8.3.5.2.3. By End-user

9. Middle East & Africa Recombinant Proteins Manufacturing Services Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Service Type
- 9.2.2. By Host Cell
- 9.2.3. By End-user
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Recombinant Proteins Manufacturing Services Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Service Type
    - 9.3.1.2.2. By Host Cell
    - 9.3.1.2.3. By End-user
- 9.3.2. UAE Recombinant Proteins Manufacturing Services Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Service Type
    - 9.3.2.2.2. By Host Cell
    - 9.3.2.2.3. By End-user
- 9.3.3. South Africa Recombinant Proteins Manufacturing Services Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Service Type
    - 9.3.3.2.2. By Host Cell
    - 9.3.3.2.3. By End-user

10. South America Recombinant Proteins Manufacturing Services Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Service Type
- 10.2.2. By Host Cell
- 10.2.3. By End-user
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Recombinant Proteins Manufacturing Services Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Service Type
    - 10.3.1.2.2. By Host Cell
    - 10.3.1.2.3. By End-user
- 10.3.2. Colombia Recombinant Proteins Manufacturing Services Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Service Type
    - 10.3.2.2.2. By Host Cell
    - 10.3.2.2.3. By End-user
- 10.3.3. Argentina Recombinant Proteins Manufacturing Services Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Service Type
    - 10.3.3.2.2. By Host Cell
    - 10.3.3.2.3. By End-user

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Recombinant Proteins Manufacturing Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Lonza Group Ltd.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Boehringer Ingelheim International GmbH
15.3. FUJIFILM Diosynth Biotechnologies USA, Inc.
15.4. Merck KGaA
15.5. Bruker Corporation
15.6. Sino Biological, Inc.
15.7. GenScript Biotech Corporation
15.8. Kaneka Corporation
15.9. Polyplus Transfection S.A.
15.10. Boster Biological Technology Co., Ltd.